{
  "meta": {
    "title": "82_Movement_Disorders",
    "url": "https://brainandscalpel.vercel.app/82-movement-disorders-caddaa6f.html",
    "scrapedAt": "2025-11-30T12:29:08.903Z"
  },
  "questions": [
    {
      "text": "Which of the following diseases primarily involves the marked structure?",
      "choices": [
        {
          "id": 1,
          "text": "Paralysis agitans"
        },
        {
          "id": 2,
          "text": "Depression"
        },
        {
          "id": 3,
          "text": "Alzheimers"
        },
        {
          "id": 4,
          "text": "Huntington chorea"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The structure marked in this transverse section of the brain at the level of superior colliculus is <strong>substantia nigra</strong>. Degeneration of substantia nigra is seen in <strong>Parkinson's disease</strong>, also known as <strong>paralysis agitans</strong>.</p>\n<p><strong>Substantia nigra</strong> is pigmented due to the presence of <strong>neuromelanin</strong> granules, which help in the synthesis of <strong>dopamine</strong>. In Parkinson's disease, there is an <strong>absence/reduced pigmentation</strong> of the substantia nigra.</p>\n<p><strong>Bradykinesia, rigidity</strong>, and <strong>resting tremor</strong> are classic features of Parkinson's disease. Because of motor disability, it is also referred to as paralysis agitans.</p>\n<p>Other options:</p>\n<p>Option B: <strong>Depression</strong> is often a comorbid finding with Parkinson's disease, but is <strong>not</strong> due to damage to the substantia nigra.</p>\n<p>Option C: <strong>Alzheimer&rsquo;s disease</strong> is the most common cause of dementia. It is due to atrophy of the entorhinal cortex, located in the <strong>medial temporal lobe</strong>.</p>\n<p>Option D: <strong>Huntington&rsquo;s chorea</strong> is an autosomal dominant disorder of movement and cognition primarily involving the <strong>striatum</strong> (caudate nucleus and putamen).</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/5f813fbb8ee5461a8455492a12746f77x600x906.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Abnormal movements</h3><p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><strong>&nbsp;Movement</strong></td>\n<td><strong>Site</strong></td>\n<td><strong>Description</strong></td>\n<td><strong>Cause</strong></td>\n</tr>\n<tr>\n<td>Intentional tremor</td>\n<td>Cerebellum</td>\n<td>Only on activity&nbsp;</td>\n<td>\n<ul>\n<li>Trauma</li>\n<li>Stroke</li>\n<li>Alcohol</li>\n<li>Drugs</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Resting tremor</td>\n<td>\n<p>Substantia nigra</p>\n<p>Red nucleus</p>\n</td>\n<td>Disappear on movement</td>\n<td>\n<ul>\n<li>&nbsp;Parkinsonism</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Hyperkinetic tremor</td>\n<td>Sympathetic overactivity&nbsp;</td>\n<td>Precipitated by emotion , stress</td>\n<td>\n<ul>\n<li>Anxiety&nbsp;</li>\n<li>Hyperthyroidism&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Asterixis</td>\n<td>Cortex</td>\n<td>Inability to sustain a muscle contraction while performing a complex motor movement</td>\n<td>\n<ul>\n<li>Hepatic encephalopathy&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Chorea</td>\n<td>Caudate nucleus and putamen</td>\n<td>&nbsp;Rapid jerky movement</td>\n<td>\n<ul>\n<li>Rheumatic chorea</li>\n<li>Huntington chorea</li>\n<li>Drug induced&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Hemibalismus</td>\n<td>Subthalamic nucleus</td>\n<td>Unilateral wild flinging violent movement of large proximal joints</td>\n<td>\n<ul>\n<li>Vascular&gt;degenerative&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Athetosis</td>\n<td>Basal ganglia- Globus Pallidum</td>\n<td>Slow writhing movement involving distal joints</td>\n<td>\n<ul>\n<li>Vascular&nbsp;</li>\n<li>Degenerative&nbsp;</li>\n<li>Infiltrative</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/71be37076f91458cbdb3a43fada1746f.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA0619",
      "difficulty": "medium"
    },
    {
      "text": "What is the most common gene mutation seen in patients with familial Parkinson's disease?",
      "choices": [
        {
          "id": 1,
          "text": "Leucine-rich repeat kinase 2"
        },
        {
          "id": 2,
          "text": "Parkin"
        },
        {
          "id": 3,
          "text": "Alpha-synuclein gene missense mutation"
        },
        {
          "id": 4,
          "text": "PTEN-induced putative kinase 1"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The most common form of monogenic familial PD is <strong>PARK8</strong>, caused by mutations in the leucine-rich repeat kinase-2 (<strong>LRRK2</strong>) <strong>gene</strong>.</p>\n<p><strong>Familial</strong> forms of <strong>parkinsonism</strong> (designated PARK1 through PARK13) have been associated with causative mutations in a number of nuclear genes. A few of these are:</p>\n<ul>\n<li>The&nbsp;<em>LRRK2</em> gene mutation&nbsp;causes autosomal dominant PD (<strong>PARK8</strong>). In this condition, Middle to late-onset PD is seen, which resembles typical PD and is responsive to levodopa.</li>\n<li>Mutations in alpha-synuclein (<strong>PARK 1 and PARK4)</strong>&nbsp;cause rare forms of familial PD and constitute the major component of Lewy bodies in sporadic PD.</li>\n<li>Parkin-associated PD <strong>(PARK 2)</strong> &amp;&nbsp;PINK1-associated PD <strong>(PARK6)</strong> are autosomal recessive seen in young-onset PD.</li>\n<li>Mutation in the glucocerebrosidase gene <strong>(<em>GBA</em>) gene</strong> of Gauchers represents the most <strong>important risk factor</strong> for the development of Parkinson's disease. Patients with PD who are GBA mutation carriers have a younger age at onset.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB8008",
      "difficulty": "hard"
    },
    {
      "text": "Which of the following features would you not expect to see in patients with Parkinson’s disease?",
      "choices": [
        {
          "id": 1,
          "text": "Genitourinary disturbances"
        },
        {
          "id": 2,
          "text": "Orthostatic hypotension"
        },
        {
          "id": 3,
          "text": "Exaggerated deep tendon reflexes"
        },
        {
          "id": 4,
          "text": "Micrographia"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Exaggerated deep tendon reflexes are not a feature of Parkinson's disease. Cardinal motor features in PD include:</p>\n<ul>\n<li>Resting tremors</li>\n<li>Bradykinesia</li>\n<li>Rigidity</li>\n<li>Gait disturbance / postural instability</li>\n</ul>\n<p>Mnemonic: TRAP - <strong>T</strong>remors + <strong>R</strong>igidity + <strong>A</strong>kinesia + <strong>P</strong>ostural instability</p>\n<ul>\n<li>Other motor features include:\n<ul>\n<li>Micrographia</li>\n<li>Masked facies (hypomimia)</li>\n<li>Reduced eye blinking</li>\n<li>Soft voice (hypophonia)</li>\n<li>Dysphagia</li>\n</ul>\n</li>\n<li>Non-motor features are:\n<ul>\n<li>Anosmia</li>\n<li>Sensory disturbance (pain)</li>\n<li>Mood Disorders (depression)</li>\n<li>Sleep disturbances (rapid eye movement behavior disorder)</li>\n<li>Autonomic:\n<ul>\n<li>GI disturbances</li>\n<li>Genitourinary disturbances</li>\n<li>Sexual dysfunction</li>\n<li>Orthostatic hypotension</li>\n</ul>\n</li>\n<li>Cognitive impairment</li>\n</ul>\n</li>\n</ul>\n<p>Parkinson&rsquo;s disease(PD)<strong>&nbsp;</strong>is the second most common neurodegenerative disorder after Alzheimer's disease.&nbsp;<strong>UK Brain Bank criteria</strong> is used for the diagnosis of PD.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7962",
      "difficulty": "easy"
    },
    {
      "text": "A 66-year-old man presents with complaints of resting tremor in his right hand, which improves with movement. He also says that he has difficulty initiating movements and his wife says his movements have been slow. On examination, rigidity is observed to passive arm movement and shuffling gait with a stooped posture is noticed.  Which of the following statements is false regarding the pathology of this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Substantia nigra pars reticulata is unaffected by the disease process"
        },
        {
          "id": 2,
          "text": "Decreased striatal dopamine is seen in this condition"
        },
        {
          "id": 3,
          "text": "Degeneration of dopaminergic neurons in the substantia nigra pars compacta"
        },
        {
          "id": 4,
          "text": "Lewy bodies which containing degenerated tau protein are seen"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The given clinical scenario is suggestive of <strong>Parkinson's disease </strong>and<strong> Lewy bodies</strong>&nbsp;seen in Parkinson's disease do not contain tau protein. They contain the protein <strong>&alpha;-synuclein.</strong></p>\n<p>Pathologic hallmarks of Parkinson's disease include:</p>\n<ul>\n<li>Degeneration of dopaminergic neurons in the <strong>substantia nigra pars compacta&nbsp;</strong>(SNc)</li>\n<li>Reduced striatal dopamine</li>\n<li>Intracytoplasmic proteinaceous inclusions called <strong>Lewy bodies,</strong> which contain the protein <strong>&alpha;-synuclein</strong></li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7972",
      "difficulty": "medium"
    },
    {
      "text": "A patient with Parkinson's disease says that he cannot even hold a coffee mug properly due to tremors. What is the frequency of the tremors likely to be?",
      "choices": [
        {
          "id": 1,
          "text": "4–6"
        },
        {
          "id": 2,
          "text": "8–10"
        },
        {
          "id": 3,
          "text": "10–12"
        },
        {
          "id": 4,
          "text": "6-10"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The frequency of <strong>resting tremors</strong> in <strong>Parkinson&rsquo;s disease</strong> is&nbsp;<strong>4&ndash;6</strong> Hz.</p>\n<p>More than 70 percent of patients with Parkinson's disease have tremors as the presenting feature. The classic parkinsonian tremor begins as a low-frequency, pill-rolling motion of the fingers, progressing to forearm pronation/supination and elbow flexion/extension.&nbsp;Other features of the tremors are:</p>\n<ul>\n<li>Typically asymmetric</li>\n<li>Occurs at rest</li>\n<li>Becomes less prominent with voluntary movement</li>\n</ul>\n<p>Frequency of various types of tremors: Physiological tremor (12 Hz ) &gt; Essential tremor (8&ndash;10 Hz) &gt; Resting tremor in PD (4&ndash;6 Hz ).</p><p>Although rest tremor is one of the diagnostic criteria for Parkinson's disease, most patients exhibit a combination of action and rest tremors.</p>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB8004",
      "difficulty": "medium"
    },
    {
      "text": "What is the most common psychiatric disturbance seen in patients with Parkinson's disease?",
      "choices": [
        {
          "id": 1,
          "text": "Anxiety"
        },
        {
          "id": 2,
          "text": "Depression"
        },
        {
          "id": 3,
          "text": "Abulia"
        },
        {
          "id": 4,
          "text": "Visual hallucination"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The <strong>most common psychiatric disturbance</strong> seen in <strong>Parkinson's disease</strong> is <strong>depression</strong>.</p>\n<p>The non-motor symptoms seen in Parkinson's disease include:</p>\n<ul>\n<li>Cognitive dysfunction and <strong>subcortical dementia</strong></li>\n<li><strong>Psychosis </strong>and<strong> hallucinations</strong> - Visual hallucinations are the most common psychotic symptom</li>\n<li>Mood disorders:\n<ul>\n<li>Depression -&nbsp;most common psychiatric disturbance</li>\n<li>Anxiety -&nbsp;second most common psychiatric disturbance&nbsp;</li>\n<li>Abulia/apathy</li>\n</ul>\n</li>\n<li>Sleep disorders - <strong>insomnia</strong>, daytime sleepiness with sleep attacks, <strong>restless leg syndrome</strong></li>\n<li><strong>Autonomic dysfunction</strong></li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC2700",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following is not an example of secondary parkinsonism?",
      "choices": [
        {
          "id": 1,
          "text": "Corticobasal syndrome"
        },
        {
          "id": 2,
          "text": "Dementia pugilistica"
        },
        {
          "id": 3,
          "text": "Post-encephalitic PD"
        },
        {
          "id": 4,
          "text": "Drug-induced Parkinsonism"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Corticobasal syndrome</strong> is not an example of&nbsp;secondary parkinsonism. It s a type of <strong>Parkinson's plus syndrome</strong>.</p>\n<p>Causes of secondary Parkinsonism include:</p>\n<ul>\n<li>Repeated head trauma&mdash;<strong>dementia pugilistica</strong></li>\n<li><strong>Drug-induced</strong></li>\n<li>Tumor</li>\n<li><strong>Post-encephalitic PD</strong></li>\n<li>Toxins: manganese, MPTP, carbon monoxide, cyanide</li>\n<li>Vascular</li>\n<li>Liver failure</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD1200",
      "difficulty": "medium"
    },
    {
      "text": "What is the most common cause of secondary parkinsonism?",
      "choices": [
        {
          "id": 1,
          "text": "Infection"
        },
        {
          "id": 2,
          "text": "Vascular"
        },
        {
          "id": 3,
          "text": "Neuroleptics"
        },
        {
          "id": 4,
          "text": "Trauma"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Dopamine-blocking agents such as <strong>neuroleptics </strong>are the <strong>most</strong>&nbsp;<strong>common </strong>cause of<strong> secondary parkinsonism.</strong></p>\n<p>Causes of secondary Parkinsonism include:</p>\n<ul>\n<li>Repeated head trauma&mdash;dementia pugilistica</li>\n<li>Drug-induced</li>\n<li>Tumor</li>\n<li>Post-encephalitic PD</li>\n<li>Toxins: manganese, MPTP, carbon monoxide, cyanide</li>\n<li>Vascular</li>\n<li>Liver failure</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB8017",
      "difficulty": "medium"
    },
    {
      "text": "A patient presented to the OPD with a shuffling gait,  slowed movements and speech,  and cogwheeling. He was started on a new drug recently. Which of the following drugs cannot cause this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Metoclopramide"
        },
        {
          "id": 2,
          "text": "Bezatropine"
        },
        {
          "id": 3,
          "text": "α-Methyldopa"
        },
        {
          "id": 4,
          "text": "Tetrabenazine"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given scenario is suggestive of <strong>secondary parkinsonism</strong>.&nbsp;<strong>Bezatropine</strong>, also known as benztropine, is used in the<strong> treatment of parkinsonism</strong>.&nbsp;It does not cause secondary parkinsonism.&nbsp;</p>\n<p>Benztropine is a centrally acting anticholinergic.&nbsp;It has been used for controlling tremors in drug-induced Parkinson's. Side effects include urinary dysfunction, glaucoma, and cognitive impairment.</p>\n<p>Drugs causing secondary parkinsonism:</p>\n<ul>\n<li>Neuroleptics (typical antipsychotics)</li>\n<li><strong>Metoclopramide</strong>, chlorpromazine</li>\n<li>Dopamine depleting agents (reserpine, tetrabenazine)</li>\n<li>Calcium channel blocker: Flunnarizine, Cinnarizine</li>\n<li>Lithium carbonate, amiodarone,&nbsp;<strong>&alpha;-Methyldopa</strong></li>\n</ul><hr><h3>Related Pearl: Medical treatment of Parkinson's disease</h3><table>\n<tbody>\n<tr>\n<td><strong>Increase dopaminergic action</strong></td>\n<td><strong>Anti cholinergics</strong></td>\n</tr>\n<tr>\n<td>\n<p><strong>Dopamine precursor</strong><strong>&nbsp; &nbsp; &nbsp; &nbsp;</strong></p>\n</td>\n<td><strong>Anti muscarinic </strong></td>\n</tr>\n<tr>\n<td>Levodopa</td>\n<td>Benzhexol (trihexyphenidyl)</td>\n</tr>\n<tr>\n<td><strong>Dopa decarboxylase inhibitor </strong></td>\n<td>Benztropine</td>\n</tr>\n<tr>\n<td>Carbedopa</td>\n<td>Procyclidine</td>\n</tr>\n<tr>\n<td>Benserazide</td>\n<td><strong>H1 antagonist </strong></td>\n</tr>\n<tr>\n<td><strong>Dopamine agonist-Ergot derivatives</strong></td>\n<td>Promethazine</td>\n</tr>\n<tr>\n<td>Bromocriptine</td>\n<td>Orphenadrine</td>\n</tr>\n<tr>\n<td>Cabergoline</td>\n<td>Diphenhydramine</td>\n</tr>\n<tr>\n<td>Pergolide</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Lisuride</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Dopamine agonist-Non ergot&nbsp;derivatives</strong></td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Ropinirole</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Pramipexole</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Rotigotine</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Apomorphine</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Dopamine facilitator </strong></td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Amantadine</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td><strong>MAO-B inhibitor </strong></td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Selegiline</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Rasagiline</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td><strong>COMT inhibitor </strong></td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Tolcapone</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Entacapone</td>\n<td>&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7984",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is a peripheral decarboxylase inhibitor?",
      "choices": [
        {
          "id": 1,
          "text": "Benserazide"
        },
        {
          "id": 2,
          "text": "Benztropine"
        },
        {
          "id": 3,
          "text": "Tetrabenazine"
        },
        {
          "id": 4,
          "text": "Trihexyphenidyl"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Benserazide</strong> is a peripheral decarboxylase inhibitor.</p>\n<p>Options B &amp; D: Benztropine and trihexyphenidyl are centrally acting anticholinergic agents.</p>\n<p>Option C: Tetrabenazine is a dopamine depleting agent. It causes drug-induced Parkinsonism.&nbsp;</p><hr><h3>Related Pearl: Medical treatment of Parkinson's disease</h3><table>\n<tbody>\n<tr>\n<td><strong>Increase dopaminergic action</strong></td>\n<td><strong>Anti cholinergics</strong></td>\n</tr>\n<tr>\n<td>\n<p><strong>Dopamine precursor</strong><strong>&nbsp; &nbsp; &nbsp; &nbsp;</strong></p>\n</td>\n<td><strong>Anti muscarinic </strong></td>\n</tr>\n<tr>\n<td>Levodopa</td>\n<td>Benzhexol (trihexyphenidyl)</td>\n</tr>\n<tr>\n<td><strong>Dopa decarboxylase inhibitor </strong></td>\n<td>Benztropine</td>\n</tr>\n<tr>\n<td>Carbedopa</td>\n<td>Procyclidine</td>\n</tr>\n<tr>\n<td>Benserazide</td>\n<td><strong>H1 antagonist </strong></td>\n</tr>\n<tr>\n<td><strong>Dopamine agonist-Ergot derivatives</strong></td>\n<td>Promethazine</td>\n</tr>\n<tr>\n<td>Bromocriptine</td>\n<td>Orphenadrine</td>\n</tr>\n<tr>\n<td>Cabergoline</td>\n<td>Diphenhydramine</td>\n</tr>\n<tr>\n<td>Pergolide</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Lisuride</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Dopamine agonist-Non ergot&nbsp;derivatives</strong></td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Ropinirole</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Pramipexole</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Rotigotine</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Apomorphine</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Dopamine facilitator </strong></td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Amantadine</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td><strong>MAO-B inhibitor </strong></td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Selegiline</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Rasagiline</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td><strong>COMT inhibitor </strong></td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Tolcapone</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Entacapone</td>\n<td>&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7987",
      "difficulty": "medium"
    },
    {
      "text": "A 68-year-old woman presents to the casualty after she tripped over a stone. She has been having trouble sleeping and abdominal discomfort. Her daughter said that she has become forgetful and her movements are very slow. She is diagnosed with Parkinson's disease. Which of her symptoms will be relieved by treatment with levodopa?",
      "choices": [
        {
          "id": 1,
          "text": "Forgetfulness"
        },
        {
          "id": 2,
          "text": "Trouble sleeping"
        },
        {
          "id": 3,
          "text": "Abdominal discomfort"
        },
        {
          "id": 4,
          "text": "Slow movements"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Levodopa is useful in alleviating the <strong>bradykinesia&nbsp;</strong>(slow movement) seen in Parkinson's disease.</p>\n<table>\n<tbody>\n<tr>\n<td colspan=\"2\">\n<p><strong>Levodopa in Parkinson's disease</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Levodopa benefits</p>\n</td>\n<td>\n<p>Classic motor symptoms of Parkinson's disease:</p>\n<ul>\n<li>Bradykinesia</li>\n<li>Rigidity</li>\n<li>Tremor</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p>Levodopa does<strong> not</strong> benefit</p>\n</td>\n<td>\n<p>Non-dopaminergic features:</p>\n<ul>\n<li>Freezing</li>\n<li>Falling</li>\n<li>Sleep disorders</li>\n<li>Dementia</li>\n<li>Autonomic dysfunction (GI disturbances, orthostatic hypotension etc.)</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Medical treatment of Parkinson's disease</h3><table>\n<tbody>\n<tr>\n<td><strong>Increase dopaminergic action</strong></td>\n<td><strong>Anti cholinergics</strong></td>\n</tr>\n<tr>\n<td>\n<p><strong>Dopamine precursor</strong><strong>&nbsp; &nbsp; &nbsp; &nbsp;</strong></p>\n</td>\n<td><strong>Anti muscarinic </strong></td>\n</tr>\n<tr>\n<td>Levodopa</td>\n<td>Benzhexol (trihexyphenidyl)</td>\n</tr>\n<tr>\n<td><strong>Dopa decarboxylase inhibitor </strong></td>\n<td>Benztropine</td>\n</tr>\n<tr>\n<td>Carbedopa</td>\n<td>Procyclidine</td>\n</tr>\n<tr>\n<td>Benserazide</td>\n<td><strong>H1 antagonist </strong></td>\n</tr>\n<tr>\n<td><strong>Dopamine agonist-Ergot derivatives</strong></td>\n<td>Promethazine</td>\n</tr>\n<tr>\n<td>Bromocriptine</td>\n<td>Orphenadrine</td>\n</tr>\n<tr>\n<td>Cabergoline</td>\n<td>Diphenhydramine</td>\n</tr>\n<tr>\n<td>Pergolide</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Lisuride</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Dopamine agonist-Non ergot&nbsp;derivatives</strong></td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Ropinirole</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Pramipexole</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Rotigotine</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Apomorphine</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Dopamine facilitator </strong></td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Amantadine</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td><strong>MAO-B inhibitor </strong></td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Selegiline</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Rasagiline</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td><strong>COMT inhibitor </strong></td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Tolcapone</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Entacapone</td>\n<td>&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7991",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following is a non-ergot dopamine agonist?",
      "choices": [
        {
          "id": 1,
          "text": "Bromocriptine"
        },
        {
          "id": 2,
          "text": "Apomorphine"
        },
        {
          "id": 3,
          "text": "Cabergoline"
        },
        {
          "id": 4,
          "text": "Pergoilde"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Apomorphine</strong> is a non-ergot dopamine agonist.</p><hr><h3>Related Pearl: Medical treatment of Parkinson's disease</h3><table>\n<tbody>\n<tr>\n<td><strong>Increase dopaminergic action</strong></td>\n<td><strong>Anti cholinergics</strong></td>\n</tr>\n<tr>\n<td>\n<p><strong>Dopamine precursor</strong><strong>&nbsp; &nbsp; &nbsp; &nbsp;</strong></p>\n</td>\n<td><strong>Anti muscarinic </strong></td>\n</tr>\n<tr>\n<td>Levodopa</td>\n<td>Benzhexol (trihexyphenidyl)</td>\n</tr>\n<tr>\n<td><strong>Dopa decarboxylase inhibitor </strong></td>\n<td>Benztropine</td>\n</tr>\n<tr>\n<td>Carbedopa</td>\n<td>Procyclidine</td>\n</tr>\n<tr>\n<td>Benserazide</td>\n<td><strong>H1 antagonist </strong></td>\n</tr>\n<tr>\n<td><strong>Dopamine agonist-Ergot derivatives</strong></td>\n<td>Promethazine</td>\n</tr>\n<tr>\n<td>Bromocriptine</td>\n<td>Orphenadrine</td>\n</tr>\n<tr>\n<td>Cabergoline</td>\n<td>Diphenhydramine</td>\n</tr>\n<tr>\n<td>Pergolide</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Lisuride</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Dopamine agonist-Non ergot&nbsp;derivatives</strong></td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Ropinirole</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Pramipexole</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Rotigotine</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Apomorphine</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Dopamine facilitator </strong></td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Amantadine</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td><strong>MAO-B inhibitor </strong></td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Selegiline</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Rasagiline</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td><strong>COMT inhibitor </strong></td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Tolcapone</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Entacapone</td>\n<td>&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7994",
      "difficulty": "medium"
    },
    {
      "text": "A 75-year-old patient presents with an inability to move and speak. He has been experiencing increasing stiffness and slowness from the past 1 hour. He has an 8-year history of Parkinson's disease and takes his levodopa-carbidopa every day. The last dose was 4 hours back. What drug should be prescribed for this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Rasagiline"
        },
        {
          "id": 2,
          "text": "Benztropine"
        },
        {
          "id": 3,
          "text": "Apomorphine"
        },
        {
          "id": 4,
          "text": "Selegillene"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The clinical features of the patient are suggestive of a <strong>severe 'off' episode</strong>. The <strong>rescue agent</strong> for the treatment of severe 'off' episodes is <strong>apomorphine</strong>.</p>\n<p>Levodopa-induced motor complications consist of fluctuations in motor response ('on' episodes when the drug is working and 'off' episodes when parkinsonian features return) and involuntary movements are known as dyskinesias which typically complicate 'on' periods.</p>\n<p>Apomorphine is&nbsp;a <strong>non-ergot dopamine agonist</strong>. It has efficacy comparable to levodopa, but it must be administered parenterally (intravenous or subcutaneous) and has a very short half-life and duration of activity (45 min).</p><p><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;The FDA recently approved opicapone, a selective COMT inhibitor as an adjunct therapy to Levodopa in patients with Parkinson's disease experiencing off episodes. &quot;}\" data-sheets-userformat=\"{&quot;2&quot;:33555327,&quot;3&quot;:{&quot;1&quot;:0},&quot;4&quot;:{&quot;1&quot;:2,&quot;2&quot;:16777215},&quot;5&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;6&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;7&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;8&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;9&quot;:1,&quot;11&quot;:4,&quot;12&quot;:0,&quot;28&quot;:1}\">The FDA recently approved opicapone, a selective COMT inhibitor as an adjunct therapy to levodopa in patients with Parkinson's disease experiencing off episodes. </span></p><hr><h3>Related Pearl: Medical treatment of Parkinson's disease</h3><table>\n<tbody>\n<tr>\n<td><strong>Increase dopaminergic action</strong></td>\n<td><strong>Anti cholinergics</strong></td>\n</tr>\n<tr>\n<td>\n<p><strong>Dopamine precursor</strong><strong>&nbsp; &nbsp; &nbsp; &nbsp;</strong></p>\n</td>\n<td><strong>Anti muscarinic </strong></td>\n</tr>\n<tr>\n<td>Levodopa</td>\n<td>Benzhexol (trihexyphenidyl)</td>\n</tr>\n<tr>\n<td><strong>Dopa decarboxylase inhibitor </strong></td>\n<td>Benztropine</td>\n</tr>\n<tr>\n<td>Carbedopa</td>\n<td>Procyclidine</td>\n</tr>\n<tr>\n<td>Benserazide</td>\n<td><strong>H1 antagonist </strong></td>\n</tr>\n<tr>\n<td><strong>Dopamine agonist-Ergot derivatives</strong></td>\n<td>Promethazine</td>\n</tr>\n<tr>\n<td>Bromocriptine</td>\n<td>Orphenadrine</td>\n</tr>\n<tr>\n<td>Cabergoline</td>\n<td>Diphenhydramine</td>\n</tr>\n<tr>\n<td>Pergolide</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Lisuride</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Dopamine agonist-Non ergot&nbsp;derivatives</strong></td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Ropinirole</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Pramipexole</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Rotigotine</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Apomorphine</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Dopamine facilitator </strong></td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Amantadine</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td><strong>MAO-B inhibitor </strong></td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Selegiline</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Rasagiline</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td><strong>COMT inhibitor </strong></td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Tolcapone</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Entacapone</td>\n<td>&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7995",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following drugs has disease-modifying action in Parkinson's disease?",
      "choices": [
        {
          "id": 1,
          "text": "Levodopa"
        },
        {
          "id": 2,
          "text": "Carbidopa"
        },
        {
          "id": 3,
          "text": "Apomorphine"
        },
        {
          "id": 4,
          "text": "Selegiline"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Selegiline</strong> is a monoamine oxidase B&nbsp;(<strong>MAO-B</strong>)<strong>&nbsp;inhibitor</strong> known to have some <strong>disease-modifying</strong> action in <strong>Parkinson's disease</strong>. Studies have&nbsp;shown that selegiline significantly delayed the time until the emergence of disability necessitating the introduction of levodopa in untreated PD patients.&nbsp;</p>\n<p>MAO-B inhibitors include:</p>\n<ul>\n<li>Selegiline</li>\n<li>Rasagiline (more potent)</li>\n</ul>\n<p><strong>Cheese effect</strong>: inhibition of MAO-A isoform prevents the metabolism of tyramine in the gut, leading to a potentially fatal hypertensive reaction called the 'cheese effect'. It can be precipitated by tyramine-rich foods such as cheese, aged meat, and red wine.</p>\n<p>Selegiline and rasagiline do not functionally inhibit MAO-A isoform and are not associated with cheese effect in doses typically used in clinical practice.</p><hr><h3>Related Pearl: Medical treatment of Parkinson's disease</h3><table>\n<tbody>\n<tr>\n<td><strong>Increase dopaminergic action</strong></td>\n<td><strong>Anti cholinergics</strong></td>\n</tr>\n<tr>\n<td>\n<p><strong>Dopamine precursor</strong><strong>&nbsp; &nbsp; &nbsp; &nbsp;</strong></p>\n</td>\n<td><strong>Anti muscarinic </strong></td>\n</tr>\n<tr>\n<td>Levodopa</td>\n<td>Benzhexol (trihexyphenidyl)</td>\n</tr>\n<tr>\n<td><strong>Dopa decarboxylase inhibitor </strong></td>\n<td>Benztropine</td>\n</tr>\n<tr>\n<td>Carbedopa</td>\n<td>Procyclidine</td>\n</tr>\n<tr>\n<td>Benserazide</td>\n<td><strong>H1 antagonist </strong></td>\n</tr>\n<tr>\n<td><strong>Dopamine agonist-Ergot derivatives</strong></td>\n<td>Promethazine</td>\n</tr>\n<tr>\n<td>Bromocriptine</td>\n<td>Orphenadrine</td>\n</tr>\n<tr>\n<td>Cabergoline</td>\n<td>Diphenhydramine</td>\n</tr>\n<tr>\n<td>Pergolide</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Lisuride</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Dopamine agonist-Non ergot&nbsp;derivatives</strong></td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Ropinirole</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Pramipexole</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Rotigotine</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Apomorphine</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Dopamine facilitator </strong></td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Amantadine</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td><strong>MAO-B inhibitor </strong></td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Selegiline</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Rasagiline</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td><strong>COMT inhibitor </strong></td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Tolcapone</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Entacapone</td>\n<td>&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7997",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following statements regarding the management of non-motor symptoms in patients with Parkinson's disease is false?",
      "choices": [
        {
          "id": 1,
          "text": "Depression should not be treated with antidepressants"
        },
        {
          "id": 2,
          "text": "Restless leg syndrome is treated by dopamine agonists"
        },
        {
          "id": 3,
          "text": "Sialorrhea  can be managed by anticholinergics"
        },
        {
          "id": 4,
          "text": "Low doses  of fludrocortisone  or midodrine provide control of autonomic symptoms"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Depression</strong> is treated with selective serotonin reuptake inhibitors (<strong>SSRIs</strong>). In cases of severe depression, other antidepressants are added.</p>\n<table>\n<tbody>\n<tr>\n<td>Manifestations in Parkinson's </td>\n<td>Treatment</td>\n</tr>\n<tr>\n<td>Depression </td>\n<td>\n<ul>\n<li><strong>SSRIs</strong></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Insomnia</td>\n<td>\n<ul>\n<li>Zolpidem</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Restless leg syndrome </td>\n<td>\n<ul>\n<li><strong>Gabapentenoids</strong></li>\n<li><strong>Dopamine agonist </strong></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Erectile dysfunction </td>\n<td>\n<ul>\n<li>Sildenafil </li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Postural hypotension </td>\n<td>\n<ul>\n<li>Rehabilitation with postural exercise </li>\n<li>Adding salt to the diet and elevating the head of the bed to prevent overnight sodium<br />natriuresis</li>\n<li>Low doses of <strong>fludrocortisone or midodrine</strong></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Sialorrhea</td>\n<td>\n<ul>\n<li><strong>Anticholinergic</strong></li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC2698",
      "difficulty": "medium"
    },
    {
      "text": "All are true about levodopa-induced motor complications except:",
      "choices": [
        {
          "id": 1,
          "text": "More likely to occur in males"
        },
        {
          "id": 2,
          "text": "Seen in younger individuals with severe disease"
        },
        {
          "id": 3,
          "text": "Seen with higher doses of levodopa"
        },
        {
          "id": 4,
          "text": "Rhythmic movements that predominantly involve the lower extremities"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Levodopa-induced motor complications</strong> are more likely to occur in <strong>females</strong>.&nbsp;</p>\n<p>The complications include transient, stereotypic, rhythmic movements that predominantly involve the lower extremities. It is seen in younger individuals with severe disease and also&nbsp;with higher doses of levodopa.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC2685",
      "difficulty": "hard"
    },
    {
      "text": "A 65-year-old woman on treatment for Parkinson’s disease is brought to the OPD. Her husband is concerned because she has been shopping a lot and reached the maximum spending limit on 2 credit cards in the past week. She has also impulsively been buying several rabbits and raising them in their home. She admits feeling guilty after her purchases. Which of the following drugs is associated with this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Dopamine precursors"
        },
        {
          "id": 2,
          "text": "Dopamine agonists"
        },
        {
          "id": 3,
          "text": "Dopamine depletors"
        },
        {
          "id": 4,
          "text": "Dopamine antagonists"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given scenario is suggestive of <strong>compulsive shopping</strong>. Pathological gambling, hypersexuality, and compulsive eating and shopping are the adverse effects of <strong>dopamine agonists</strong>. Levodopa can also cause these effects, but to a lesser extent than dopamine agonists.</p><hr><h3>Related Pearl: Medical treatment of Parkinson's disease</h3><table>\n<tbody>\n<tr>\n<td><strong>Increase dopaminergic action</strong></td>\n<td><strong>Anti cholinergics</strong></td>\n</tr>\n<tr>\n<td>\n<p><strong>Dopamine precursor</strong><strong>&nbsp; &nbsp; &nbsp; &nbsp;</strong></p>\n</td>\n<td><strong>Anti muscarinic </strong></td>\n</tr>\n<tr>\n<td>Levodopa</td>\n<td>Benzhexol (trihexyphenidyl)</td>\n</tr>\n<tr>\n<td><strong>Dopa decarboxylase inhibitor </strong></td>\n<td>Benztropine</td>\n</tr>\n<tr>\n<td>Carbedopa</td>\n<td>Procyclidine</td>\n</tr>\n<tr>\n<td>Benserazide</td>\n<td><strong>H1 antagonist </strong></td>\n</tr>\n<tr>\n<td><strong>Dopamine agonist-Ergot derivatives</strong></td>\n<td>Promethazine</td>\n</tr>\n<tr>\n<td>Bromocriptine</td>\n<td>Orphenadrine</td>\n</tr>\n<tr>\n<td>Cabergoline</td>\n<td>Diphenhydramine</td>\n</tr>\n<tr>\n<td>Pergolide</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Lisuride</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Dopamine agonist-Non ergot&nbsp;derivatives</strong></td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Ropinirole</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Pramipexole</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Rotigotine</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Apomorphine</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Dopamine facilitator </strong></td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Amantadine</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td><strong>MAO-B inhibitor </strong></td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Selegiline</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Rasagiline</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td><strong>COMT inhibitor </strong></td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Tolcapone</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Entacapone</td>\n<td>&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC2688",
      "difficulty": "medium"
    },
    {
      "text": "A patient with Parkinson's disease has been scheduled to undergo deep brain stimulation. What is the target site for this procedure?",
      "choices": [
        {
          "id": 1,
          "text": "Subthalamic nucleus and globus pallidus internus"
        },
        {
          "id": 2,
          "text": "Subthalamic nucleus and globus pallidus externus"
        },
        {
          "id": 3,
          "text": "Substantia nigra pars compacta and globus pallidus externus"
        },
        {
          "id": 4,
          "text": "Substantia nigra pars reticulata and globus pallidus internus"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The target site for <strong>deep brain stimulation</strong> in <strong>Parkinson&rsquo;s disease</strong> is the <strong>subthalamic nucleus (STN)</strong> and <strong>globus pallidus internus (GPi).</strong></p>\n<p>It helps improve tremors and reduce both 'off' time and dyskinesia. It does not improve features that fail to respond to levodopa. It does not prevent the development or progression of non-dopaminergic features such as freezing, falling, and dementia.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7999",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is an example of Parkinson's plus syndrome?",
      "choices": [
        {
          "id": 1,
          "text": "Progressive supranuclear palsy"
        },
        {
          "id": 2,
          "text": "Dementia pugilistica"
        },
        {
          "id": 3,
          "text": "Post-encephalitic PD"
        },
        {
          "id": 4,
          "text": "Drug-induced Parkinsonism"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Progressive supranuclear palsy</strong> is an example of <strong>Parkinson's plus syndrome</strong>.&nbsp;</p>\n<p>Parkinson's plus syndrome or <strong>atypical parkinsonism</strong> refers to a group of conditions that present with parkinsonism (rigidity and bradykinesia) but are different from PD due to underlying differences in clinical manifestations and pathology. They may have&nbsp;degeneration of the striatum, globus pallidus, cerebellum, and brainstem as well as the SNc. These include multiple system atrophy (MSA), progressive supranuclear palsy (PSP), and corticobasal syndrome (CBS).</p>\n<p><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;PSP is often misdiagnosed as Parkinson&rsquo;s disease (PD). The substantia nigra is damaged in both diseases and this accounts for the overlapping symptoms which are observed, particularly in the initial stages. In PSP, impairment of cognitive functions occurs before the motor or ocular signs and this serves as an important distinguishing feature.&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:829,&quot;3&quot;:{&quot;1&quot;:0},&quot;5&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;6&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;7&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;8&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;11&quot;:4,&quot;12&quot;:0}\">PSP is often misdiagnosed as Parkinson&rsquo;s disease (PD). The substantia nigra is damaged in both diseases and this accounts for the overlapping symptoms which are observed.&nbsp; In PSP, impairment of cognitive functions occurs before the motor or ocular signs and this serves as an important distinguishing feature.</span></p>\n<p>Immunohistochemistry broadly classifies them into two subtypes: <strong>synucleopathies </strong>and<strong> tauopathies</strong>.</p><hr><h3>Related Pearl: Synucleinopathies and tauopathies</h3><div dir=\"ltr\"><span><strong>Synucleinopathies:</strong></span></div>\n<ul>\n<li dir=\"ltr\"><span>Parkinson&rsquo;s disease</span></li>\n<li dir=\"ltr\"><span>Dementia with Lewy bodies</span></li>\n<li dir=\"ltr\"><span>Multiple system atrophy</span></li>\n<li dir=\"ltr\"><span>REM behavioral disorder</span></li>\n<li dir=\"ltr\"><span>Pure autonomic failure</span>&nbsp;</li>\n</ul>\n<div dir=\"ltr\"><span><strong>Tauopathies:</strong></span></div>\n<ul>\n<li dir=\"ltr\"><span>Alzheimer&rsquo;s disease</span></li>\n<li dir=\"ltr\"><span>Down syndrome</span></li>\n<li dir=\"ltr\"><span>Progressive supranuclear palsy</span></li>\n<li dir=\"ltr\"><span>Corticobasal degeneration</span></li>\n<li dir=\"ltr\"><span>Pick&rsquo;s disease/frontotemporal dementia</span></li>\n<li dir=\"ltr\"><span>Chronic traumatic encephalopathy/punch drunk syndrome/dementia pugilistica</span></li>\n<li dir=\"ltr\"><span>Postencephalitic parkinsonism</span></li>\n<li dir=\"ltr\"><span>Pantothenate kinase-associated degeneration</span></li>\n<li dir=\"ltr\"><span>Niemann Pick disease type C</span></li>\n<li dir=\"ltr\"><span>Subacute sclerosing panencephalitis</span></li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7976",
      "difficulty": "easy"
    },
    {
      "text": "Which among the following features is not expected in a patient with atypical parkinsonism?",
      "choices": [
        {
          "id": 1,
          "text": "Late speech and gait impairment"
        },
        {
          "id": 2,
          "text": "Absence of rest tremor"
        },
        {
          "id": 3,
          "text": "Poor or no response to levodopa"
        },
        {
          "id": 4,
          "text": "No motor asymmetry"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Early speech</strong> and <strong>gait impairment</strong> are seen in <strong>atypical parkinsonism</strong>.</p>\n<p>Features of atypical parkinsonism include:</p>\n<ul>\n<li>Early speech and gait impairment</li>\n<li><strong>Absence of rest tremor</strong></li>\n<li><strong>No motor asymmetry</strong></li>\n<li><strong>Poor or no response to levodopa</strong></li>\n<li>Aggressive clinical course</li>\n<li>Symptoms of severe early autonomic involvement</li>\n<li>Early severe dementia also points towards atypical parkinsonism</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB8015",
      "difficulty": "medium"
    },
    {
      "text": "A 60-year-old man presented with Parkinsonism and cerebellar features. MRI showed the finding as shown in the image. What is the likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Drug induced parkinsonism"
        },
        {
          "id": 2,
          "text": "Multiple systems atrophy"
        },
        {
          "id": 3,
          "text": "Dementia pugilistica"
        },
        {
          "id": 4,
          "text": "Progressive supranuclear palsy"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Parkinsonism, cerebellar features, and the 'hot cross bun' sign on&nbsp;MRI suggest <strong>multiple system atrophy</strong> (MSA).</p>\n<div class=\"page\" title=\"Page 3168\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>MSA manifests as a combination of parkinsonian, cerebellar, and autonomic features. Based on predominant clinical features it is further divided into :</p>\n<ul>\n<li>MSA-P:\n<ul>\n<li>Predominantly parkinsonian features are seen</li>\n<li>T2 weighted MRI demonstrates <strong>hyperintense putaminal rim</strong></li>\n</ul>\n</li>\n<li>MSA-C:\n<ul>\n<li>Predominantly cerebellar features are seen</li>\n<li>MRI shows cerebellar and brainstem atrophy causing <strong>pontine hot cross bun sign</strong></li>\n</ul>\n</li>\n</ul>\n</div>\n</div>\n</div>\n</div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/a24937c7b9ed4bf1a324b505ba92107a.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7979",
      "difficulty": "medium"
    },
    {
      "text": "All of the following are the core clinical features for the diagnosis of Lewy body dementia except:",
      "choices": [
        {
          "id": 1,
          "text": "Fluctuating cognition"
        },
        {
          "id": 2,
          "text": "Recurrent visual hallucination"
        },
        {
          "id": 3,
          "text": "REM sleep behavior disorder"
        },
        {
          "id": 4,
          "text": "Orthostatic hypotension"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Orthostatic hypotension</strong> is <strong>not</strong> a <strong>core </strong>clinical feature of <strong>Lewy body dementia</strong> (LBD) as per <strong>DSM-5</strong>.</p>\n<p><strong>LBD</strong> also known as dementia with Lewy bodies is the second most type of <strong>progressive dementia</strong> after Alzheimer&rsquo;s disease. <strong>Protein deposits</strong>, called <strong>Lewy bodies</strong>, deposit in <strong>nerve cells</strong> in the <strong>brain</strong> region involved in thinking, memory, and movement (motor control)</p>\n<p><strong>Core features</strong> of LBD as per DSM-5 are <strong>fluctuating cognition</strong>, <strong>attention</strong>, <strong>alertness</strong>, <strong>recurrent visual hallucination,</strong> and <strong>Parkinsonian symptoms</strong>. Suggestive features are REM sleep behavior disorder and severe neuroleptic sensitivity.<br />Orthostatic hypotension, erectile dysfunction, and constipation are other features of LBD.</p>\n<p>Treatment of LBD includes <strong>rivastigmine</strong> and <strong>donepezil</strong> which may improve cognition, and reduce hallucinosis and delusion. <strong>Pimavanserin</strong> may be used to treat <strong>psychosis</strong>.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB9050",
      "difficulty": "medium"
    },
    {
      "text": "A 60-year-old man presented with Parkinsonian features which is unresponsive to levodopa. MRI image is given below. What is the probable diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Progressive supranuclear palsy"
        },
        {
          "id": 2,
          "text": "Multiple system atrophy type C"
        },
        {
          "id": 3,
          "text": "Hallevorden spatz disease"
        },
        {
          "id": 4,
          "text": "Parkinson's disease"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>An elderly male with a history of features of <strong>Parkinsonism nonresponsive to levodopa</strong> should raise suspicion for <strong>Parkinson plus syndromes</strong> which include <strong>progressive supranuclear palsy (PSP).</strong></p>\n<p>Progressive supranuclear palsy (PSP), also known as the Steele-Richardson-Olszewski syndrome, is a <strong>tauopathy</strong> and is considered a neurodegenerative disease with no current efficacious treatment. It is characterized by decreased cognition, abnormal eye movements (supranuclear vertical gaze palsy), postural instability and falls, as well as parkinsonian features and speech disturbances. </p>\n<p>The <strong>atrophy of the midbrain</strong> results in <strong>hummingbird sign</strong> of the brainstem (in the sagittal plane). The <strong>preserved pons</strong> form the body of the bird, and the atrophic midbrain, the head, with beak extending anteriorly towards the optic chiasm. Midbrain atrophy is best confirmed with the reduction in the midbrain to pons ratio.</p>\n<p><strong>Mickey mouse appearance, </strong>which is the reduction of anteroposterior midline midbrain diameter, at the level of the superior colliculi is seen on axial imaging.</p>\n<p>The following image shows the hummingbird sign:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/0547b0e825084b15ae58a7245aa70786x510x506.GIF\" alt=\"Explanation Image\"><p><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;According to a recent imaging study data, the insula and frontal cortex seem to be involved in the development of anxiety in adults with Parkinson's disease.&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:33563519,&quot;3&quot;:{&quot;1&quot;:0},&quot;4&quot;:{&quot;1&quot;:2,&quot;2&quot;:6989903},&quot;5&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;6&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;7&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;8&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;9&quot;:0,&quot;11&quot;:4,&quot;12&quot;:0,&quot;16&quot;:10,&quot;28&quot;:1}\">According to a recent imaging study data, the insula and frontal cortex seem to be involved in the development of anxiety in adults with Parkinson's disease.</span></p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/3380e875f2444465a4ef96ae52e8c73c.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5412",
      "difficulty": "medium"
    },
    {
      "text": "An 8-year-old girl exhibits rapid, semi-purposeful, graceful, dance-like, involuntary movements. What is this finding?",
      "choices": [
        {
          "id": 1,
          "text": "Hemiballismus"
        },
        {
          "id": 2,
          "text": "Myoclonus"
        },
        {
          "id": 3,
          "text": "Chorea"
        },
        {
          "id": 4,
          "text": "Athetosis"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Rapid, semi-purposeful, graceful, dance-like, involuntary movements are seen in <strong>chorea</strong>.</p>\n<table>\n<tbody>\n<tr>\n<td colspan=\"2\">\n<p><strong>Hyperkinetic movement disorders:</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tremor</p>\n</td>\n<td>\n<p>Rhythmic oscillation of a body part due to intermittent muscle contractions</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Dystonia</p>\n</td>\n<td>\n<p>Involuntary, sustained or repeated muscle contractions often associated with twisting movements and abnormal posture</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Athetosis</p>\n</td>\n<td>\n<p>Slow, distal, writhing, involuntary movements with a propensity to affect arms and hands</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Chorea</p>\n</td>\n<td>\n<p>Rapid, semi-purposeful, graceful, dance-like, non patterned, involuntary movements involving distal or proximal muscle groups</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Myoclonus</p>\n</td>\n<td>\n<p>Sudden, brief (&lt;100ms), jerk-like arrhythmic muscle twitches</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tics</p>\n</td>\n<td>\n<p>Brief, repeated, stereotyped muscle contractions that can often be suppressed for a short time</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Sydenham's chorea (also called St. Vitus's dance) is a type of chorea that is typically seen in childhood (5-15 years) with prior exposure to group A streptococcal infection and is thought to be autoimmune in nature. It is characterized by the acute onset of choreiform movements and behavioral disturbances and is self-limiting. </p><hr><h3>Related Pearl: Abnormal movements</h3><p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><strong>&nbsp;Movement</strong></td>\n<td><strong>Site</strong></td>\n<td><strong>Description</strong></td>\n<td><strong>Cause</strong></td>\n</tr>\n<tr>\n<td>Intentional tremor</td>\n<td>Cerebellum</td>\n<td>Only on activity&nbsp;</td>\n<td>\n<ul>\n<li>Trauma</li>\n<li>Stroke</li>\n<li>Alcohol</li>\n<li>Drugs</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Resting tremor</td>\n<td>\n<p>Substantia nigra</p>\n<p>Red nucleus</p>\n</td>\n<td>Disappear on movement</td>\n<td>\n<ul>\n<li>&nbsp;Parkinsonism</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Hyperkinetic tremor</td>\n<td>Sympathetic overactivity&nbsp;</td>\n<td>Precipitated by emotion , stress</td>\n<td>\n<ul>\n<li>Anxiety&nbsp;</li>\n<li>Hyperthyroidism&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Asterixis</td>\n<td>Cortex</td>\n<td>Inability to sustain a muscle contraction while performing a complex motor movement</td>\n<td>\n<ul>\n<li>Hepatic encephalopathy&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Chorea</td>\n<td>Caudate nucleus and putamen</td>\n<td>&nbsp;Rapid jerky movement</td>\n<td>\n<ul>\n<li>Rheumatic chorea</li>\n<li>Huntington chorea</li>\n<li>Drug induced&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Hemibalismus</td>\n<td>Subthalamic nucleus</td>\n<td>Unilateral wild flinging violent movement of large proximal joints</td>\n<td>\n<ul>\n<li>Vascular&gt;degenerative&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Athetosis</td>\n<td>Basal ganglia- Globus Pallidum</td>\n<td>Slow writhing movement involving distal joints</td>\n<td>\n<ul>\n<li>Vascular&nbsp;</li>\n<li>Degenerative&nbsp;</li>\n<li>Infiltrative</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB8006",
      "difficulty": "easy"
    },
    {
      "text": "During rounds, you see that a patient diagnosed with stroke exhibits wild, flinging movements on his right side. Where is the lesion likely to be?",
      "choices": [
        {
          "id": 1,
          "text": "Caudate nucleus"
        },
        {
          "id": 2,
          "text": "Putamen"
        },
        {
          "id": 3,
          "text": "Subthalamic nucleus"
        },
        {
          "id": 4,
          "text": "Red nucleus"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Unilateral wild, flinging movements are called <strong>hemiballismus</strong> and is seen due to a lesion in the <strong>subthalamic nucleus. </strong>The most common cause of hemiballismus is stroke.</p><hr><h3>Related Pearl: Abnormal movements</h3><p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><strong>&nbsp;Movement</strong></td>\n<td><strong>Site</strong></td>\n<td><strong>Description</strong></td>\n<td><strong>Cause</strong></td>\n</tr>\n<tr>\n<td>Intentional tremor</td>\n<td>Cerebellum</td>\n<td>Only on activity&nbsp;</td>\n<td>\n<ul>\n<li>Trauma</li>\n<li>Stroke</li>\n<li>Alcohol</li>\n<li>Drugs</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Resting tremor</td>\n<td>\n<p>Substantia nigra</p>\n<p>Red nucleus</p>\n</td>\n<td>Disappear on movement</td>\n<td>\n<ul>\n<li>&nbsp;Parkinsonism</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Hyperkinetic tremor</td>\n<td>Sympathetic overactivity&nbsp;</td>\n<td>Precipitated by emotion , stress</td>\n<td>\n<ul>\n<li>Anxiety&nbsp;</li>\n<li>Hyperthyroidism&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Asterixis</td>\n<td>Cortex</td>\n<td>Inability to sustain a muscle contraction while performing a complex motor movement</td>\n<td>\n<ul>\n<li>Hepatic encephalopathy&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Chorea</td>\n<td>Caudate nucleus and putamen</td>\n<td>&nbsp;Rapid jerky movement</td>\n<td>\n<ul>\n<li>Rheumatic chorea</li>\n<li>Huntington chorea</li>\n<li>Drug induced&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Hemibalismus</td>\n<td>Subthalamic nucleus</td>\n<td>Unilateral wild flinging violent movement of large proximal joints</td>\n<td>\n<ul>\n<li>Vascular&gt;degenerative&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Athetosis</td>\n<td>Basal ganglia- Globus Pallidum</td>\n<td>Slow writhing movement involving distal joints</td>\n<td>\n<ul>\n<li>Vascular&nbsp;</li>\n<li>Degenerative&nbsp;</li>\n<li>Infiltrative</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB8012",
      "difficulty": "easy"
    },
    {
      "text": "What is the most common acute drug-induced movement disorder?",
      "choices": [
        {
          "id": 1,
          "text": "Akathisia"
        },
        {
          "id": 2,
          "text": "Dystonia"
        },
        {
          "id": 3,
          "text": "Tardive Dyskinesia"
        },
        {
          "id": 4,
          "text": "Myoclonus"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The <strong>most common</strong> acute<strong> drug-induced movement disorder</strong> is&nbsp;<strong>dystonia</strong>.</p>\n<p>Drug-induced movement disorders<strong>&nbsp;</strong>are primarily associated with drugs that block dopamine receptors(neuroleptics) or central dopaminergic transmission. Neuroleptics are the commonest&nbsp;cause of this condition. Drug-induced movement disorders are classified as:</p>\n<ul>\n<li><strong>Acute</strong>: Dystonia is the most common acute hyperkinetic drug reaction; generalized in children, focal in adults.</li>\n<li><strong>Subacute</strong>: Akathisia is the commonest reaction in this category</li>\n<li><strong>Tardive syndromes: </strong>Develop after months to years of initiation of the drug.\n<ul>\n<li>Tardive dyskinesia is the most common. Choreiform movements affecting the mouth, lips, and tongue are seen. In severe cases, trunks, limbs, and respiratory muscles may also be affected.</li>\n<li>In one third, TD remits within 3 months of stopping the drug and improvement occur over several years.</li>\n</ul>\n</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB8016",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is the most common movement disorder?",
      "choices": [
        {
          "id": 1,
          "text": "Dystonia"
        },
        {
          "id": 2,
          "text": "Chorea"
        },
        {
          "id": 3,
          "text": "Athetosis"
        },
        {
          "id": 4,
          "text": "Essential tremor"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The most common movement disorder is&nbsp;<strong>essential tremor</strong>.</p>\n<p>It can present in childhood but dramatically increases in prevalence over the age of 70 years. Essential tremor is characterized by a high-frequency tremor <strong>6-10 Hz</strong> that&nbsp;predominantly affects the upper extremities.</p>\n<p>The tremor is characteristically<strong> improved by alcohol</strong> and <strong>worsened by stress</strong>.</p>\n<table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td>Essential tremor</td>\n<td>Parkinson's disease</td>\n</tr>\n<tr>\n<td>Bradykinesia，<br />rigidity， micrographia</td>\n<td>Absent</td>\n<td>Present</td>\n</tr>\n<tr>\n<td>Tremor</td>\n<td>Usually postural</td>\n<td>Usually resting</td>\n</tr>\n<tr>\n<td>Tone</td>\n<td>Normal</td>\n<td>Cogwheel rigidity</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC2710",
      "difficulty": "medium"
    },
    {
      "text": "A 65-year-old man presents with a tremor in both hands that worsens when he is trying to eat or write something. He says that it gets worse when he is stressed and reduces when he drinks wine. His father also had similar symptoms. On examination, there are no resting tremors. Which of the following drugs can be used to control this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Valproate"
        },
        {
          "id": 2,
          "text": "Levetiracetam"
        },
        {
          "id": 3,
          "text": "Primidone"
        },
        {
          "id": 4,
          "text": "Carbamazepine"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given scenario is suggestive of <strong>essential tremor</strong>. It&nbsp;can be controlled by <strong>primidone</strong>.</p>\n<p>The drugs used to treat essential tremors are:</p>\n<ul>\n<li>Beta-blockers:&nbsp;propranolol, atenolol</li>\n<li>Anticonvulsants:\n<ul>\n<li>Primidone</li>\n<li>Gabapentine</li>\n<li>Topiramate</li>\n</ul>\n</li>\n</ul>\n<p>In severe and drug-resistant cases, surgical treatment involves targeting the <strong>ventral intermediate (VIM)&nbsp;nucleus of the thalamus</strong>.&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC2716",
      "difficulty": "medium"
    },
    {
      "text": "A 70-year-old male patient is scheduled to undergo deep brain stimulation for essential tremor. What is the target site for the procedure?",
      "choices": [
        {
          "id": 1,
          "text": "Subthalamic nucleus and globus pallidus internus"
        },
        {
          "id": 2,
          "text": "Anterior limb of internal capsule"
        },
        {
          "id": 3,
          "text": "Substantia nigra pars compacta"
        },
        {
          "id": 4,
          "text": "Ventral intermediate nucleus of thalamus"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The target for <strong>deep brain stimulation</strong> in <strong>essential tremor</strong> is<strong> ventral intermediate </strong>(VIM) nucleus of the thalamus.</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Disease</strong></p>\n</td>\n<td>\n<p><strong>Target sites for deep brain stimulation</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Parkinson&rsquo;s disease</p>\n</td>\n<td>\n<p>Subthalamic nucleus (STN)</p>\n<p>Globus pallidus internus (GPi)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Dystonia</p>\n</td>\n<td>\n<p>Globus pallidus internus (GPi)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Depression</p>\n</td>\n<td>\n<p>Anterior limb of internal capsule and cingulum</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Obsessive-Compulsive Disorder&nbsp;(OCD)</p>\n</td>\n<td>\n<p>Anterior limb of the internal capsule</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Essential tremor</p>\n</td>\n<td>\n<p>Ventral intermediate (VIM) nucleus</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB8001",
      "difficulty": "medium"
    },
    {
      "text": "A patient with a family history of Huntington's disease has come for genetic counselling. All of the following are true about this condition, except:",
      "choices": [
        {
          "id": 1,
          "text": "Autosomal dominant inheritance"
        },
        {
          "id": 2,
          "text": "Trinucleotide repeat of CAG sequence"
        },
        {
          "id": 3,
          "text": "Westphal akinetic variant has good prognosis"
        },
        {
          "id": 4,
          "text": "Early onset cognitive impairment seen"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Westphal akinetic variant</strong> has the <strong>worst prognosis</strong>.</p>\n<p>Huntington's disease shows an <strong>autosomal dominant inheritance</strong>. It is a <strong>trinucleotide repeat expansion</strong> disease with multiple CAG repeats (&gt;40 repeats) in the coding region of the huntingtin gene on chromosome 4p. It demonstrates genetic anticipation with earlier onset if inherited from the father.</p>\n<p>It presents in the second to third decade of life with cognitive impairment as an early feature.&nbsp;The dominant cognitive feature of HD is executive dysfunction. Additionally, dementia is seen later as the disease progresses.</p>\n<p>Decreased acetylcholine leads to dementia. Decreased GABA and increased dopamine lead to chorea. Treatment consists of haloperidol, tetrabenazine (Dopamine depletor).</p>\n<p>The following image shows MRI showing dilated ventricles (ex vacuo ventriculomegaly)- due to atrophy of caudate and putamen:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/f3cd4fcd53c84a809407548d00b8c999x1280x1575.JPEG\" alt=\"Explanation Image\"><p>MRI showing&nbsp;atrophy of caudate and putamen</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/94daa957c157440d9216e91069083745x1280x1576.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC2727",
      "difficulty": "medium"
    },
    {
      "text": "St. Vitus' dance is the other name for which of the following conditions?",
      "choices": [
        {
          "id": 1,
          "text": "Huntigton's chorea"
        },
        {
          "id": 2,
          "text": "Sydenham's chorea"
        },
        {
          "id": 3,
          "text": "Athetosis"
        },
        {
          "id": 4,
          "text": "Hemibalismus"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Sydenham's chorea</strong> was originally called St. Vitus's dance.</p>\n<p>Sydenham's chorea is more common in females. It is typically seen in childhood (5-1 5 years)&nbsp;with prior exposure to group A streptococcal infection and is thought to be autoimmune in nature.</p>\n<p>It is characterized by the acute onset of choreiform movements and behavioral disturbances.</p>\n<p>It is self limited.Treatment is generally restricted to those with severe chorea.The chorea generally responds to dopamine-blocking agents, valproic acid, and carbamazepine.&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC2735",
      "difficulty": "medium"
    },
    {
      "text": "All of the following features can be seen in patients with restless leg syndrome, except:",
      "choices": [
        {
          "id": 1,
          "text": "Symptoms worsen during the evening or night"
        },
        {
          "id": 2,
          "text": "Accompanied by an unpleasant sensation in the legs"
        },
        {
          "id": 3,
          "text": "Symptoms that begin or worsen with activity"
        },
        {
          "id": 4,
          "text": "Partial or complete relief by movement"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>In restless leg syndrome (RLS), <strong>symptoms begin</strong> or worsen with <strong>rest</strong>. It is also called as Willis-Ekbom disease.</p>\n<p>The four core symptoms required for the diagnosis of RLS are:</p>\n<ul>\n<li>An urge to move the legs</li>\n<li>Usually caused or accompanied by an <strong>unpleasant sensation</strong> in the legs (creepy-crawly feeling, paresthesia, or burning)</li>\n<li>Symptoms that begin or worsen with rest and partial or complete <strong>relief by movement</strong></li>\n<li>Worsening during the evening or night</li>\n</ul>\n<div class=\"ng-scope\">\n<div class=\"ng-scope\">\n<p>Restless leg syndrome is a typical&nbsp;<strong>sensory-motor disorder</strong>&nbsp;that generally affects the legs during rest periods, especially sleep. There is an&nbsp;<strong>irresistible urge</strong>&nbsp;to<strong>&nbsp;shake</strong>&nbsp;the<strong>&nbsp;legs</strong>&nbsp;associated with&nbsp;<strong>burning sensation, itching,</strong>&nbsp;and&nbsp;<strong>cramps</strong>&nbsp;of the legs. In idiopathic cases, dopaminergic hypofunction is postulated.</p>\n<p>In patients with restless legs syndrome,<strong>&nbsp;iron stores</strong>&nbsp;are initially repleted, and the aggravating factors are eliminated. If RLS still persists, initial therapy with a&nbsp;<strong>gabapentinoid</strong>&nbsp;(pregabalin, gabapentin, gabapentin enacarbil) is preferred, rather than a dopamine agonist (pramipexole, ropinirole, rotigotine). This is due to the high frequency of intermediate and long-term augmentation with dopamine agonists, as well as their risk of impulse control disorders.</p>\n<p><strong>FDA-approved</strong>&nbsp;drugs for the&nbsp;<strong>treatment</strong>&nbsp;of restless leg syndrome:&nbsp;</p>\n<ul>\n<li>Gabapentin</li>\n<li>Ropinirole</li>\n<li>Pramipexole</li>\n<li>Rotigotine&nbsp;</li>\n</ul>\n<p>A dopamine agonist is used as an alternative in patients with increased risk for side effects from gabapentinoids, such as those with obesity and its complications, a past or present history of moderate to severe depression, a disorder causing gait instability or respiratory failure, and a history of substance use disorder.</p>\n</div>\n</div>\n<p>Non-pharmacological treatments that can be used in restless leg syndrome are:</p>\n<ul>\n<li>Avoiding alcohol at bedtime</li>\n<li>Massaging affected legs</li>\n<li>Hot baths</li>\n<li>Applying hot or cold to the affected area</li>\n<li>Engaging in moderate exercises</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC2739",
      "difficulty": "easy"
    }
  ]
}